
Join to view full profile
10604 South West HughwayChicago Ridge, IL 60415
Phone+1 708-424-9710
Fax+1 708-671-9282
Dr. Kelta is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mouhammed Kelta is an oncologist based in Chicago Ridge, IL. Dr. Kelta completed a fellowship in Hematology and Medical Oncology at the University of Illinois College of Medicine at Chicago and a residency in Internal Medicine at Chicago Medical School/Rosalind Franklin University of Medicine & Science, following an MD from the University of Aleppo Faculty of Medicine. Dr. Kelta has expertise in myeloproliferative disease and has contributed to the field with publications on topics such as high-dose chemotherapy in Hodgkin's lymphoma and febrile neutropenia. Notable publications include work in the journals Tumori, Journal of Infection and Public Health, and Annals of Hematology.
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1994 - 1997
Chicago Medical School/Rosalind Franklin University of Medicine & ScienceResidency, Internal Medicine, 1991 - 1994
University of Aleppo Faculty of MedicineClass of 1986, MD
Certifications & Licensure
IL State Medical License 1993 - 2029
WI State Medical License 1993 - 2027
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsHigh-dose chemotherapy and peripheral hematopoietic stem cell transplantation in relapsed/refractory Hodgkin's lymphoma.Mouhammed Kelta, Jamal Zekri, Ehab Mosaad Abdelghany, Jalil Ur Rehman, Zahid Amin Khan
Tumori. 2018-05-08 - 10 citationsA de-escalation protocol for febrile neutropenia cases and its impact on carbapenem resistance: A retrospective, quasi-experimental single-center study.Abeer N. Alshukairi, Haleema Ali Alserehi, Aiman El-Saed, Mouhammed Kelta, Jalil Ur Rehman
Journal of Infection and Public Health. 2016-07-01 - 5 citationsBrentuximab-induced hand-foot syndrome in a Hodgkin lymphoma patient.Jalil Ur Rehman, Mouhammed Kelta, Basim AlBeirouti, Radwi Ghazala Rashidhaider, Bayoumy Mohamed
Annals of Hematology. 2016-02-01
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









